Abstract
Cisplatin is a platinum-based chemotherapeutic that has long since been effective against a variety of solid-cancers, substantially improving the five-year survival rates for cancer patients. Its use has also historically been limited by its adverse drug reactions, or cisplatin-induced toxicities (CITs). Of these reactions, cisplatin-induced nephrotoxicity (CIN), cisplatin-induced peripheral neuropathy (CIPN), and cisplatin-induced ototoxicity (CIO) are the three most common of several CITs recognised thus far. While the anti-cancer activity of cisplatin is well understood, the mechanisms driving its toxicities have only begun to be defined. Most of the literature pertains to damage caused by oxidative stress that occurs downstream of cisplatin treatment, but recent evidence suggests that the instigator of CIT development is inflammation. Cisplatin has been shown to induce pro-inflammatory signalling in CIN, CIPN, and CIO, all of which are associated with persisting markers of inflammation, particularly from the innate immune system. This review covered the hallmarks of inflammation common and distinct between different CITs, the role of innate immune components in development of CITs, as well as current treatments targeting pro-inflammatory signalling pathways to conserve the use of cisplatin in chemotherapy and improve long-term health outcomes of cancer patients.
Funder
Canadian Institutes of Health Research
Women and Children’s Health Research Institute
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference327 articles.
1. The Successful Regression of Large Solid Sarcoma 180 Tumors by Platinum Compounds;Rosenberg;Cancer Res.,1970
2. Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
3. Ueber die Einwirkung des Ammoniaks auf Platinchlorur [On the Action of Ammonia on Platinum Chloride];Peyrone;Ann. Chemi Pharm.,1845
4. The resurgence of platinum-based cancer chemotherapy
5. The Mechanism of Action of Antitumor Platinum Compounds;Roberts;Prog. Nucleic Acid Res. Mol. Biol.,1979
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献